In vitro effects of a novel silver-based complex on influenza virus; Journal of Pharmacology and Pharmacotherapeutics; Vol. 4, iss. 9

Bibliographische Detailangaben
Parent link:Journal of Pharmacology and Pharmacotherapeutics
Vol. 4, iss. 9.— 2018.— [P. 186-190]
1. Verfasser: Silnikov V. A. Vladimir
Körperschaft: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий (ИШХБМТ)
Weitere Verfasser: Plotnikov E. V. Evgeny Vladimirovich
Zusammenfassung:Title screen
Objective: To study the mechanism of antiviral activity of a new silver-based compound of general formula C6H19Ag2N4 LiO6S2 on influenza virus. Materials and Methods: Antiviral properties were investigated on test culture of Madin–Darby canine kidney (MDCK) cells with serial tenfold dilutions of the influenza virus. The completeness of viral inactivation was confirmed by determining the virus titer after a double passage of virus-containing suspension in MDCK cell culture. Reverse transcription polymerase chain reaction analysis of viral RNA, enzyme immunoassay, and transmission electron microscopy for morphological analysis of influenza virus particles were applied for analysis of viral RNA and effect of substance influence. Results: The results indicate a significant change in the antigenic structure of viral proteins of influenza virus by the silver-containing complex. The main inactivation mechanism of influenza virus by the action of the silver-containing complex is associated primarily with the effect on virion protein structure rather than cleavage of the viral RNA. It was revealed that the mechanism for the inactivation of influenza virus is not associated with cleavage of viral RNA corresponding genes M, NS, or nucleoprotein but more probable with changes of the antigen determinants of virion. It was found a significant damaging effect on influenza virus under action of tested substance at concentration higher than 0.4 mM. Conclusion: The novel silver-based complex possesses antiviral properties and could be considered as a prospective antiviral drug.
Sprache:Englisch
Veröffentlicht: 2018
Schlagworte:
Online-Zugang:http://earchive.tpu.ru/handle/11683/57714
http://dx.doi.org/10.4103/jpp.JPP_50_18
Format: Elektronisch Buchkapitel
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=660150

MARC

LEADER 00000naa0a2200000 4500
001 660150
005 20250331143650.0
035 |a (RuTPU)RU\TPU\network\29118 
090 |a 660150 
100 |a 20190429d2018 k||y0rusy50 ba 
101 0 |a eng 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a In vitro effects of a novel silver-based complex on influenza virus  |f V. A. Silnikov, E. V. Plotnikov 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 26 tit.] 
330 |a Objective: To study the mechanism of antiviral activity of a new silver-based compound of general formula C6H19Ag2N4 LiO6S2 on influenza virus. Materials and Methods: Antiviral properties were investigated on test culture of Madin–Darby canine kidney (MDCK) cells with serial tenfold dilutions of the influenza virus. The completeness of viral inactivation was confirmed by determining the virus titer after a double passage of virus-containing suspension in MDCK cell culture. Reverse transcription polymerase chain reaction analysis of viral RNA, enzyme immunoassay, and transmission electron microscopy for morphological analysis of influenza virus particles were applied for analysis of viral RNA and effect of substance influence. Results: The results indicate a significant change in the antigenic structure of viral proteins of influenza virus by the silver-containing complex. The main inactivation mechanism of influenza virus by the action of the silver-containing complex is associated primarily with the effect on virion protein structure rather than cleavage of the viral RNA. It was revealed that the mechanism for the inactivation of influenza virus is not associated with cleavage of viral RNA corresponding genes M, NS, or nucleoprotein but more probable with changes of the antigen determinants of virion. It was found a significant damaging effect on influenza virus under action of tested substance at concentration higher than 0.4 mM. Conclusion: The novel silver-based complex possesses antiviral properties and could be considered as a prospective antiviral drug. 
461 |t Journal of Pharmacology and Pharmacotherapeutics 
463 |t Vol. 4, iss. 9  |v [P. 186-190]  |d 2018 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a antiviral activity 
610 1 |a influenza virus 
610 1 |a monoclonal antibodies 
610 1 |a polymerase chain reaction 
610 1 |a silver-based complex 
610 1 |a противовирусные препараты 
610 1 |a вирусы 
610 1 |a грипп 
610 1 |a моноклональные антитела 
610 1 |a полимеразная цепная реакция 
700 1 |a Silnikov  |b V. A.  |g Vladimir 
701 1 |a Plotnikov  |b E. V.  |c chemist  |c Associate Professor of Tomsk Polytechnic University, Candidate of Chemical Sciences  |f 1983-  |g Evgeny Vladimirovich  |3 (RuTPU)RU\TPU\pers\32469  |9 16417 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Исследовательская школа химических и биомедицинских технологий (ИШХБМТ)  |c (2017- )  |3 (RuTPU)RU\TPU\col\23537 
801 2 |a RU  |b 63413507  |c 20200130  |g RCR 
856 4 |u http://earchive.tpu.ru/handle/11683/57714 
856 4 |u http://dx.doi.org/10.4103/jpp.JPP_50_18 
942 |c CF